Discovering microbial enzymes to improve probiotics
Chemoproteomic discovery of secreted microbial enzymes for engineered probiotics
This study is looking at how certain enzymes made by gut bacteria can help make probiotics work better, which could lead to improved health for people dealing with different health issues.
Quick facts
| Grant type | Fellowship grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California-Irvine NIH-funded |
| Lab location | 1 site (Irvine, United States) |
| Project ID | NIH-11058361 on NIH RePORTER |
What this research studies
This research investigates how specific enzymes produced by gut bacteria can be harnessed to enhance the effectiveness of probiotics. By using advanced chemoproteomic techniques, the study aims to identify and characterize these enzymes, which play a crucial role in modulating immune responses and other biological processes. The goal is to develop probiotics that can better regulate the levels of important metabolites in the body, potentially leading to improved health outcomes for patients with various conditions. Patients may benefit from a deeper understanding of how gut microbiota influences their health and the development of more effective probiotic treatments.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals with inflammatory diseases, microbial infections, or cancers who may benefit from enhanced probiotic therapies.
Not a fit: Patients who do not have any gut-related health issues or those who are not interested in probiotic treatments may not receive benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the creation of probiotics that significantly improve immune function and overall health.
How similar studies have performed: Previous research has shown promise in using microbial enzymes to influence health outcomes, indicating that this approach could be a valuable advancement in probiotic therapy.
Where this research is happening
Irvine, United States
- University of California-Irvine — Irvine, United States (Active)
Researchers
- Principal investigator: Falco, Natalie — University of California-Irvine
- Study coordinator: Falco, Natalie
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.